NeoTract Announces American Urological Association (AUA) Recommendation of UroLift® System as a Standard of Care Option for the Treatment of Enlarged Prostate
In its newly released clinical guidelines developed by a panel of experts in the field, the AUA recommends that the UroLift Prostatic Urethral Lift procedure should be considered for the management of men’s lower urinary tract symptoms attributed to BPH. The guidelines, last revised in 2010, were distributed to peer reviewers prior to approval by the AUA Board of Directors.
The AUA notes that, given the strong observed relationship between erectile dysfunction and BPH, this group of men is at high risk for sexual dysfunction. The organization recommends that patients should be counselled about the sexual side effects of any surgical intervention and should be made aware that surgical treatment can cause ejaculatory dysfunction and may worsen erectile dysfunction. The UroLift System is the only minimally invasive treatment option that has been shown to provide rapid and durable symptomatic and urinary flow rate improvement without inducing sustained sexual dysfunction.
“The AUA is strongly committed to doing what is best for patients. With
the inclusion of the UroLift System in these new guidelines, the AUA
provides support of the UroLift System as a treatment in the best
interest of patients,” said
BPH is marked by bothersome urinary symptoms that can cause loss of productivity, depression, interrupted sleep, and decreased quality of life. It is not a pre-cursor to prostate cancer, but is twelve times more common, especially as men age. Over 40 percent of men in their 50s have BPH and over 70 percent of men in their 60s have the condition. The incidence rate climbs to 80 percent for men over the age of 70. If BPH is left untreated, the condition can worsen over time and cause permanent bladder damage.
UroLift System Results to be Featured in Late-Breaker at AUA Annual Meeting
Additionally, the company announced activities planned for the 113th
Video session presentation by Dr.
Thomas Mueller: Performance of Prostatic Urethral Lift in Men with Prostate Volumes <30 grams and >80 grams (7:30 – 9:30 a.m., MCC WEST, 3002)
UroLift technique video presentation by Dr.
Gregg Eure: Surgical Techniques: Tips & Tricks: Benign Prostatic Hyperplasia (3:00 – 4:00 p.m., MCC South, Esplanade)
Late-breaking abstract presentation by Dr.
Daniel Rukstalis: Multi-Center Prospective Study of the Prostatic Urethral Lift for Obstructive Median Lobe: The MedLift Study, An Extension of the LIFT Randomized Study (4:05 – 4:15 p.m.in MCC North, Hall E)
Moderated poster presentation by Dr.
Steven Kaplan: Predictors of Response to the Prostatic Urethral Lift Treatment (1:00 – 3:00 p.m.in MCC West, 3006)
About the UroLift System
About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of
For Teleflex Incorporated
Jake Elguicze, 610-948-2836
Treasurer and Vice President, Investor Relations
Nicole Osmer, 650-454-0505